Navigation Links
GSK - Improving Performance to Continue in Second Half
Date:7/22/2009

LONDON, July 22 /PRNewswire-FirstCall/ -- GSK announced its sales and turnover fell by less than expected in Q2. The Pharma giant also said there had been good growth in the consumer, vaccine, european and emerging markets businesses and whilst the US remains under pressure from older products going off patent, the rate of decline has slowed down.

Talking about the improving outlook for the second half of the year, Andrew Witty, GSK Chief Executive, said: "As we go into the second half of the year I expect to see those trends continue and, on top of that we will see significant orders being fulfilled, for example, in pandemic vaccine orders. So H1N1 or Swine 'Flu. We'll also see increased volumes of Relenza, our antiviral, being shipped as well as the kick-in of a series of new products."

The full interview and transcript are available now on http://w3.cantos.com/glaxosmithkline.

It's free to view. All you need to do is register at http://www.cantos.com. Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives.

If you would like to contact us, please email enquiries@cantos.com or phone +44-207-936-1333.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
2. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
3. Womens Folic Acid Levels Improving
4. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
5. Jefferson researchers find personalized interventions key to improving colon cancer screening rates
6. McKesson Corporation CEO to Address the Detroit Economic Club on Preserving Our Healthcare System and Improving Quality of Life
7. Occupational therapy is an effective way of improving the daily life of stroke patients
8. Novel Approach to Improving Cardiovascular Care
9. Improving doctor-patient communication yields significant health benefits
10. IOM advisory: improving cancer patients psychosocial care
11. Improving Europes image

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...-USNewswire/ -- Congressman Chaka Fattah (D-PA) is...s Senate,s vote tonight to proceed to debate on Af...Arlen Specter and Bob Casey deserve the thanks of ...stand-up, critical votes in the Senate tonight adv...h Care Reform legislation to full debate. The Pres...
(Date:11/21/2009).../ -- Milvia Lopez, by her attorney MICHAEL STEWART...n Supreme Court, New York County, bearing Index # ...Lopez underwent a routine transesophageal echocard...s used an HIV infected scope exposing her to HIV. ...fter being discharged from the procedure and arriv...
(Date:11/21/2009)...l credentialing software company IntelliSoft Group...p with Amerinet, Inc., the leading healthcare G.P....sform quality care within the healthcare market. ...9 -- ISG Group, LLC, doing business as IntelliSoft...t Inc., a leading national healthcare group purcha...
(Date:11/21/2009)...l Group merges their practice with that of E. Stev... (PRWEB) November 21, 2009 -- The New H... Gibson, Dr. Dean Cloutier, Dr. John Plachtyna and...g practice with that of esteemed colleague Dr. E. ...nted to retire from dentistry in order to concentr...
(Date:11/20/2009)...ire-USNewswire/ -- The American Academy of Actuar...form legislation released this week to contain str...dual coverage mandate. The actuaries said that an ...verse selection stemming from more restrictive iss..."The individual mandate language should be strengt...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2
...ene Therapeutics Research Institute at Cedars-Sina...t it is possible to sustain therapeutic gene expre...ar, even in the presence of an anti-viral immune r...vel gutted adenoviral vector called HC-Adv, is com...
...rm outcomes, researchers say , THURSDAY, Oct. 25 (...rial natriuretic peptide (ANP) can lessen cardiac ...omes, a new study finds. , According to a Japanese...usion injuries," caused when blood rushes back to ...
...compare more than 500 health pla...26 U.S.News & World Report and the,National Commi...he third,edition of America,s Best Health Plans, a...families face health plan,selection options, the r...
...k Engineer and Information, Technology Magazines ..., ABBOTT PARK, Ill., Oct. 26 Abbott (NYSE: ABT ... diversity in two publications.,Abbott was named a...rsity in the magazine. In addition, Abbott was,nam...
...lth Plans, Lists for Third ...e third consecutive year,HealthPlus of Michigan,s ...,plans have been recognized by U.S. News & World R...are and Medicaid in the,national news magazine,s U...
...and,House Democratic leaders held a news conferenc...n the revised bipartisan SCHIP bill, which passed ...pening remarks:, "Today we took another step forw...ation where on the motion to recommit,the Republic...
Other Medicine News:Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 2Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 3Health News:Abbott Again Honored as a Leader in Diversity 2Health News:Abbott Again Honored as a Leader in Diversity 3
(Date:11/20/2009)...ov. 20 Soligenix, Inc. (...y), formerly known as DOR BioPharma, Inc., a late-...it has formed a consortium to develop thermostable... acting vaccines. Soligenix received a $9.4 millio... Infectious Diseases (NIAID), a division of the Na...
(Date:11/19/2009)...Nov. 19 BioCryst Pharmac...e pricing of a public offering of 5,000,000 shares... in gross proceeds of $48.75 million. All of the ...n effective shelf registration statement previousl...n. BioCryst has also granted the underwriters a 3...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3OPAXIO 28TM 29 Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annu 5050 1Open innovation networks are one key to improved care 58222 1Open innovation networks are one key to improved care 58222 2Open innovation networks are one key to improved care 58222 3Open innovation networks are one key to improved care 58222 4Open innovation networks are one key to improved care 58222 5Fish fend off invading germs with an initial response similar to the one found in people 10082 1Fish fend off invading germs with an initial response similar to the one found in people 10082 2
... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), ...oday announced that it will present updated result...one-year survival data, during a,poster discussion...Study of,Lung Cancer,s (IASLC) 12th World Conferen... Poster number: PD6-1-1 Title: A phase 2 study o...
... (Nasdaq:,VICL) announced today that results from ...using a plasmid DNA (pDNA) vaccine developed by th...Vical, reinforced previously,reported Phase 1 conc...,vaccine regimen was safe and well-tolerated, and ...in up to 70% of the vaccine recipients. "These re...
Other Medicine Technology:Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 2Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 3Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: